{"disease":{"id":"rotavirus-infection","name":"rotavirus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04010448","title":"A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":8200,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT03870061","title":"Evaluation of an Infant Immunization Encouragement Program in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":5187,"lead_sponsor_name":"GiveWell","has_results":false},{"nct_id":"NCT03207750","title":"This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1280,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03483116","title":"A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":true},{"nct_id":"NCT06080906","title":"Phase II Clinical Trial of the Inactivated Rotavirus Vaccine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Institute of Medical Biology, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03313128","title":"SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance","phase":"","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT00443846","title":"RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02992197","title":"The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"University of Vermont","has_results":true},{"nct_id":"NCT05032391","title":"Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Limited Liability Company Pharm Aid","has_results":false},{"nct_id":"NCT06962904","title":"CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT06485258","title":"CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT05037435","title":"Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Limited Liability Company Pharm Aid","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}